Tag Archives: SNDX

Top 5 Clean Energy Stocks To Invest In Right Now

What happened 

Shares of natural gas fuel supplier Clean Energy Fuels Corp (NASDAQ:CLNE) jumped as much as 12% in trading Tuesday as oil prices continued to help push the stock higher. At 3:30 p.m. EDT shares were near their high for the day, trading 11.6% higher. 

So what

The ups and downs of crude oil trading can often drive Clean Energy Fuels’ stock and that appears to be what’s happening today. Midday, oil prices spiked on news that the Trump Administration would ban all oil imports from Iran by Nov. 4, 2018. WTI Crude Oil is trading 3.5% higher at $70.45 per barrel and Brent Crude is currently up 2.2% to $76.34 per barrel.

Image source: Getty Images.

Since Clean Energy Fuels’ natural gas products are a direct competitor to diesel, which comes from crude oil, when oil prices rise it makes natural gas more competitive. For today, investors are speculating that rising oil prices will eventually help the company’s financials. 

Top 5 Clean Energy Stocks To Invest In Right Now: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at last week’s top performing penny stocks, we’ll show you a small-cap stock with real growth potential that just popped up on our radar…

    Penny Stock Current Share Price Last Week’s Gain
    New Age Beverage Corp. (NADAQ: NBEV) $3.94 286.79%
    India Globalization Capital Inc. (NYSE: IGC) $2.18 181.55%
    Ascent Capital Group Inc. (NASDAQ: ASCMA) $2.16 103.85%
    Netlist Inc. (NASDAQ: NLST) $0.73 80.56%
    Oragenics Inc. (NYSE: OGEN) $0.92 71.63%
    Astrotech Corp. (NASDAQ: ASTC) $3.44 68.37%
    Command Security Corp. (NYSE: MOC) $2.77 51.09%
    Oasmia Pharmaceuticals (NASDAQ: OASM) $3.57 50.66%
    NovaBay Pharmaceuticals Inc. (NYSE: NBY) $2.10 48.15%
    Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.25 45.72%

    While the gains these stocks made are exciting, they also highlight the danger of investing in penny stocks.

  • [By Money Morning Staff Reports]

    After looking at last week’s top performing penny stocks, we’ll show you a penny stock that’s on the verge of bringing you triple-digit returns…

    Penny Stock Current Share Price Last Week’s Gain
    Orchids Paper Products Co. (NYSE: TIS) $2.60 218.83%
    China Rapid Finance Ltd. (NYSE: XRF) $2.69 69.01%
    Cel-Sci Corp. (NYSE: CVM) $1.21 42.17%
    Regulus Therapeutics Inc. (Nasdaq: RGLS) $0.29 33.40%
    Farmmi Inc. (Nasdaq: FAMI) $3.82 30.51%
    Biolase Inc. (Nasdaq: BIOL) $1.85 29.93%
    Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.18 26.99%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $0.92 25.56%
    Inpixon (Nasdaq: INPX) $0.14 24.36%
    JMU Ltd. (Nasdaq: JMU) $1.58 24.05%

    While some of those returns look spectacular, we’re not convinced these penny stocks will keep growing.

Top 5 Clean Energy Stocks To Invest In Right Now: TCP Capital Corp.(TCPC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TCP Capital (NASDAQ:TCPC)‘s stock had its “buy” rating restated by equities research analysts at National Securities in a research report issued to clients and investors on Monday. They presently have a $17.00 price objective on the investment management company’s stock. National Securities’ price target indicates a potential upside of 17.24% from the stock’s previous close.

  • [By Lee Jackson]

    This is a solid business development company (BDC) with shares that have acted well this year. Blackrock TPC Capital Corp. (NASDAQ: TCPC) is an externally managed specialty finance company focused on middle-market lending. The company has elected to be regulated as a BDC under the Investment Company Act of 1940.

  • [By Joseph Griffin]

    TCP Capital (NASDAQ:TCPC) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BlackRock TCP Capital (TCPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Clean Energy Stocks To Invest In Right Now: Ramco-Gershenson Properties Trust(RPT)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ramco-Gershenson Properties Trust (RPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Ramco-Gershenson Properties Trust  (NYSE:RPT)Q4 2018 Earnings Conference CallFeb. 21, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    ILLEGAL ACTIVITY WARNING: “Ramco-Gershenson Properties Trust (RPT) Releases FY19 Earnings Guidance” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4166975/ramco-gershenson-properties-trust-rpt-releases-fy19-earnings-guidance.html.

  • [By Max Byerly]

    Ramco-Gershenson Properties Trust (NYSE:RPT) was upgraded by research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Shane Hupp]

    KeyCorp set a $15.00 price target on Ramco-Gershenson Properties Trust (NYSE:RPT) in a research note published on Wednesday. The brokerage currently has a buy rating on the real estate investment trust’s stock. KeyCorp also issued estimates for Ramco-Gershenson Properties Trust’s Q3 2018 earnings at $0.32 EPS, Q4 2018 earnings at $0.32 EPS, FY2018 earnings at $1.29 EPS, Q1 2019 earnings at $0.32 EPS, Q2 2019 earnings at $0.31 EPS, Q3 2019 earnings at $0.32 EPS, Q4 2019 earnings at $0.32 EPS and FY2019 earnings at $1.27 EPS.

  • [By Joseph Griffin]

    Ramco-Gershenson Properties Trust (NYSE:RPT) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Tuesday.

Top 5 Clean Energy Stocks To Invest In Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Syndax Pharmaceuticals (NASDAQ:SNDX) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a report issued on Friday.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Logan Wallace]

    A number of brokerages have recently issued reports on SNDX. B. Riley began coverage on shares of Syndax Pharmaceuticals in a research report on Tuesday, January 8th. They issued a “buy” rating and a $40.00 price target on the stock. ValuEngine downgraded shares of Syndax Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Zacks Investment Research downgraded shares of Syndax Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Wednesday, January 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $16.25.

    COPYRIGHT VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Set to Announce Earnings on Thursday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4188416/syndax-pharmaceuticals-sndx-set-to-announce-earnings-on-thursday.html.

    About Syndax Pharmaceuticals

  • [By Jon C. Ogg]

    Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) was started with a Buy rating and assigned a $30 price target at H.C. Wainwright on July 12. This is a small $175 million market cap company at the time of the call, but the price target in this call was about 300% higher than the $7.10 closing price. Syndax has a 52-week range of $6.61 to $15.20, and its most recent closing price was $7.49. The cancer pipeline has been the focus for such large upside here, and at one point one analyst was pointing to Syndax rallying to as high as $40.

Top 5 Clean Energy Stocks To Invest In Right Now: Cohen & Steers Quality Income Realty Fund Inc(RQI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cohen & Steers Quality Income Realty Inc (NYSE:RQI) declared a monthly dividend on Monday, June 18th, Wall Street Journal reports. Shareholders of record on Wednesday, August 22nd will be given a dividend of 0.08 per share by the real estate investment trust on Friday, August 31st. This represents a $0.96 annualized dividend and a yield of 7.66%. The ex-dividend date is Tuesday, August 21st.

  • [By Ethan Ryder]

    First Republic Investment Management Inc. purchased a new position in shares of Cohen & Steers Quality Income Realty Inc (NYSE:RQI) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 32,456 shares of the real estate investment trust’s stock, valued at approximately $390,000.

Top 10 Medical Stocks To Buy For 2019

If you’re like most people getting ready to retire, you’re probably counting on Social Security benefits to cover a big portion of your living expenses. Unfortunately, many future retirees significantly underestimate how much of their Social Security check is likely to be eaten up by one big expense: healthcare. 

In fact, future retirees responding to a recent survey conducted by Nationwide significantly underestimated the percentage of their Social Security benefits likely to go toward their care as they age. 

The good news is, while costly health issues are a fact of life for many seniors, there are steps you can take to try to keep costs affordable and make sure you still have enough Social Security left to live on — even after paying for medical help. 

Image source: Getty Images.

Top 10 Medical Stocks To Buy For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) was started with a Buy rating and assigned a $30 price target at H.C. Wainwright on July 12. This is a small $175 million market cap company at the time of the call, but the price target in this call was about 300% higher than the $7.10 closing price. Syndax has a 52-week range of $6.61 to $15.20, and its most recent closing price was $7.49. The cancer pipeline has been the focus for such large upside here, and at one point one analyst was pointing to Syndax rallying to as high as $40.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Top 10 Medical Stocks To Buy For 2019: Core-Mark Holding Company Inc.(CORE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core-Mark (CORE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Rhumbline Advisers decreased its holdings in Core-Mark Holding Company, Inc. (NASDAQ:CORE) by 10.2% in the first quarter, HoldingsChannel reports. The firm owned 106,505 shares of the business services provider’s stock after selling 12,145 shares during the quarter. Rhumbline Advisers’ holdings in Core-Mark were worth $2,264,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core-Mark (CORE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019: BancorpSouth, Inc.(BXS)

Advisors’ Opinion:

  • [By Max Byerly]

    QCR (NASDAQ: QCRH) and Bancorpsouth Bank (NYSE:BXS) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

  • [By Logan Wallace]

    Brean Capital reaffirmed their hold rating on shares of Bancorpsouth Bank (NYSE:BXS) in a research report released on Sunday.

    Other analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Bancorpsouth Bank from a hold rating to a buy rating and set a $38.00 price objective for the company in a report on Tuesday, June 19th. Stephens restated a buy rating and set a $37.00 price objective on shares of Bancorpsouth Bank in a report on Monday, August 27th. Eight investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $35.57.

  • [By Stephan Byrd]

    Bancorpsouth Bank (NYSE:BXS) has been given an average recommendation of “Hold” by the eleven analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $35.13.

Top 10 Medical Stocks To Buy For 2019: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Top 10 Medical Stocks To Buy For 2019: Benchmark Electronics, Inc.(BHE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Benchmark Electronics, Inc. (NYSE:BHE) declared a quarterly dividend on Monday, September 17th, RTT News reports. Shareholders of record on Friday, September 28th will be given a dividend of 0.15 per share by the technology company on Thursday, October 11th. This represents a $0.60 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Thursday, September 27th.

Top 10 Medical Stocks To Buy For 2019: Willis Lease Finance Corporation(WLFC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Willis Lease Finance Co. (NASDAQ:WLFC) CEO Charles F. Iv Willis sold 4,718 shares of the firm’s stock in a transaction on Tuesday, June 26th. The shares were sold at an average price of $31.19, for a total transaction of $147,154.42. Following the sale, the chief executive officer now owns 706,058 shares in the company, valued at approximately $22,021,949.02. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Top 10 Medical Stocks To Buy For 2019: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of B&G Foods, Inc. (NYSE:BGS) have been given a consensus rating of “Hold” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $34.67.

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    B&G Foods (NYSE: BGS) – Look in your pantry or your fridge or your freezer, there’s a better than 50% chance you got a couple of this company’s brands on the shelf. This $28 billion packaged food firm has been quietly acquiring old brands and breathing new and profitable life into them. Reviving stalwarts, such as Ortega, Cream of Wheat and Green Giant, and making headway with progressive, younger brands such as Skinny Girl and Pirate’s Booty (which my 16-year-old seems to live off), the company pulled in $1.6 billion in annual revenue last year while delivering a mind-boggling 24.7% return on equity. While officially a consumer staple stock, B&G is in growth mode through acquisition as displayed through its superior ROE. Shares trade at a 31% discount to their 52-week high. The stock trades at $28 (a 31with a forward PE of 13.41 and a compelling 6.78% dividend yield.

Top 10 Medical Stocks To Buy For 2019: MEI Pharma, Inc.(MEIP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on MEI Pharma (MEIP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Headlines about MEI Pharma (NASDAQ:MEIP) have been trending somewhat negative on Friday, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MEI Pharma earned a coverage optimism score of -0.06 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.5534769772513 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Money Morning News Team]

    Seadrill’s rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill’s gains already on the books, we’ll look at a stock that’s on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

    Penny Stock Current Share Price Law Week’s Gain
    Seadrill Ltd. (NYSE: SDRL) $0.58 98.74%
    Vivis Inc. (Nasdaq: VVUS) $0.83 59.97%
    MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40%
    Transenterix Inc. (NYSE: TRXC) $3.15 35.72%
    Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58%
    Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22%
    Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37%
    Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03%
    21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

    These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

  • [By Ethan Ryder]

    Shares of MEI Pharma Inc (NASDAQ:MEIP) were up 13.2% during trading on Wednesday . The company traded as high as $4.30 and last traded at $4.30. Approximately 651,334 shares were traded during trading, an increase of 127% from the average daily volume of 287,125 shares. The stock had previously closed at $3.80.

Top 10 Medical Stocks To Buy For 2019: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Mallinckrodt PLC (NYSE: MNK) traded down about 3.5% Friday to post a new 52-week low of $11.65 after closing Thursday at $12.07. The stock’s 52-week high is $49.12. Volume was about 10% below the daily average of around 3.9 million shares. The company had no specific news.

  • [By Stephan Byrd]

    Canaccord Genuity set a $34.00 price objective on Mallinckrodt (NYSE:MNK) in a research report released on Sunday. The firm currently has a hold rating on the stock.

  • [By Stephan Byrd]

    Shares of Mallinckrodt PLC (NYSE:MNK) have been given a consensus recommendation of “Hold” by the twenty-two brokerages that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $27.44.

  • [By Sean Williams]

    After running a screen for healthcare stocks with a PEG ratio below 1 (courtesy of Yahoo! Finance), the following 13 were all that remained:

    Innoviva (NASDAQ:INVA): 0.42 PEG ratio Celgene (NASDAQ:CELG): 0.54 Mallinckrodt (NYSE:MNK): 0.59 Exelixis (NASDAQ:EXEL): 0.60 Global Cord Blood Corp.: 0.72 AbbVie: 0.75 Vertex Pharmaceuticals: 0.80 DaVita: 0.80 Supernus Pharmaceuticals: 0.80 Mednax: 0.82 MiMedx Group: 0.88 CIGNA: 0.93 Medpace Holdings: 0.95

    Image source: Getty Images.

  • [By Dan Caplinger]

    Wall Street moved lower on Thursday, with the Dow Jones Industrial Average suffering a 201-point decline. Stocks took their cues from the bond market, where bond prices dropped sharply in response to extremely strong U.S. economic data. For years, the economic expansion has given bond investors a Goldilocks scenario, in which growth was solid but not so sharp as to cause negative side effects, such as inflation. Now, stronger signals could force the Federal Reserve to raise interest rates more aggressively than previously thought, and that could hurt the markets. Several individual companies also suffered from bad news that sent their shares lower. Mallinckrodt (NYSE:MNK), International Speedway (NASDAQ:ISCA), and LGI Homes (NASDAQ:LGIH) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Medical Stocks To Buy For 2019: Nuveen AMT-Free Municipal Income Fund(NEA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Wells Fargo & Company MN raised its holdings in Nuveen AMT-Free Municipal (NYSE:NEA) by 8.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 4,674,452 shares of the company’s stock after buying an additional 372,370 shares during the period. Wells Fargo & Company MN’s holdings in Nuveen AMT-Free Municipal were worth $60,768,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    BB&T Securities LLC cut its holdings in Nuveen Amt-Free Quality Municpl Incm Fnd (NYSE:NEA) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,949 shares of the company’s stock after selling 10,037 shares during the quarter. BB&T Securities LLC owned about 0.10% of Nuveen Amt-Free Quality Municpl Incm Fnd worth $3,392,000 at the end of the most recent quarter.

Best Heal Care Stocks To Invest In Right Now

The economy has shifted into high gear, with corporate profits surging, bankruptcies and foreclosures tumbling and the national unemployment rate easing to 3.8%, an 18-year low.

Americans have become more optimistic, but their personal finances don’t necessarily mirror the economy’sprogress. The latest assessment of household financial health by the Federal Reserve shows “many signs of growth and improvement, along with remaining pockets of distress and fragility, according to its May report.

Has your ownfinancialstatus climbed to nearan all-time high? If not, here are some actions worth heeding:

Finda better,steadier job

With unemployment so low, now might be the time to find a new job if you can,while the getting’sgood. Thatlow 3.8%rate masks a darker secret a lot of jobs paypoorly orfeature irregular work hoursor other undesirablequalities. Three in 10 adults have unsteady income, according to theFed survey, which included responses from more than 12,000 Americans.

Best Heal Care Stocks To Invest In Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: Newcastle Investment Corporation(NCT)

Advisors’ Opinion:

  • [By Shane Hupp]

    PolySwarm (CURRENCY:NCT) traded 5.6% lower against the U.S. dollar during the 1-day period ending at 22:00 PM E.T. on July 4th. One PolySwarm token can now be purchased for $0.0039 or 0.00000059 BTC on major cryptocurrency exchanges including HitBTC, IDEX and DDEX. During the last seven days, PolySwarm has traded 8.4% higher against the U.S. dollar. PolySwarm has a total market cap of $5.94 million and $28,632.00 worth of PolySwarm was traded on exchanges in the last day.

  • [By Joseph Griffin]

    PolySwarm (CURRENCY:NCT) traded 3.5% lower against the dollar during the 1 day period ending at 0:00 AM Eastern on June 2nd. PolySwarm has a market cap of $9.94 million and $67,420.00 worth of PolySwarm was traded on exchanges in the last 24 hours. One PolySwarm token can currently be purchased for $0.0068 or 0.00000089 BTC on major exchanges including HitBTC, DDEX and IDEX. In the last week, PolySwarm has traded 8.2% lower against the dollar.

Best Heal Care Stocks To Invest In Right Now: Transdigm Group Incorporated(TDG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TransDigm Group Incorporated (NYSE:TDG) reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $338.99 and last traded at $336.77, with a volume of 4675 shares. The stock had previously closed at $335.00.

  • [By Joseph Griffin]

    Astronics (NASDAQ: ATRO) and TransDigm Group (NYSE:TDG) are both aerospace companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Shane Hupp]

    TransDigm Group (NYSE:TDG) insider Roger Jones sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $323.78, for a total value of $1,618,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Logan Wallace]

    TransDigm Group (NYSE:TDG) had its price objective hoisted by Canaccord Genuity from $350.00 to $375.00 in a report released on Friday morning. The firm currently has a positive rating on the aerospace company’s stock.

Best Heal Care Stocks To Invest In Right Now: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

  • [By Max Byerly]

    Provident Financial Services (NYSE: PFS) and BCB Bancorp (NASDAQ:BCBP) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Joseph Griffin]

    Clifton Bancorp (NASDAQ: CSBK) and Provident Financial Services (NYSE:PFS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Top China Stocks To Invest In 2018

(Published Feb. 23 by Bob Ciura)

Shares of consumer products company Nu Skin Enterprises (NYSE:NUS) crashed 11% after the company missed analyst expectations on both sales and earnings per share for the fourth quarter.

Nu Skin has struggled mightily over the past three years. In January 2014, the company was hit with an investigation by Chinese regulatory authorities into the firm’s business practices.

But it’s not all bad news – Nu Skin’s earnings are growing, and the stock has a 3% dividend yield.

Plus, Nu Skin raised its dividend by 1.4% after providing its earnings report.

This makes 16 years in a row of annual dividend hikes. Nu Skin is a group of 272 stocks with 10+ years of consecutive dividend increases, known as the Dividend Achievers.

You can see the full Dividend Achievers List here.

Nu Skin has come a long way since the investigation, and has made meaningful strides in turning around the China business.

Top China Stocks To Invest In 2018: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

Top China Stocks To Invest In 2018: GlobalSCAPE, Inc.(GSB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Akorn, Inc. (NASDAQ: AKRX) fell 32.7 percent to $13.25 in pre-market trading after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 15.7 percent to $12.30 in pre-market trading. Subsea 7 confirmed a $7.00 per share proposal to acquire Mcdermott, pending termination of merger agreement with CB&I.
    Myomo, Inc. (NYSE: MYO) fell 9 percent to $3.65 in pre-market trading after rising 11.39 percent on Friday.
    Hasbro, Inc. (NASDAQ: HAS) fell 8 percent to $88.36 in pre-market trading after the company reported weaker-than-expected results for its first quarter on Monday.
    SunPower Corporation (NASDAQ: SPWR) fell 7.1 percent to $9.00 in pre-market trading.
    Endeavour Silver Corp. (NYSE: EXK) shares fell 5.9 percent to $2.88 in pre-market trading after declining 3.16 percent on Friday.
    Mattel, Inc. (NASDAQ: MAT) shares fell 5.5 percent to $12.25 in pre-market trading.
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares fell 5.1 percent to $2.96 in pre-market trading after rising 76.27 percent on Friday.
    GlobalSCAPE, Inc. (NYSE: GSB) fell 5.1 percent to $3.57 in pre-market trading.
    Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) shares fell 4.1 percent to $49.93 in pre-market trading.
    Oasis Petroleum Inc. (NYSE: OAS) fell 4.1 percent to $9.75 in pre-market trading. SunTrust Robinson Humphrey downgraded Oasis Petroleum from Hold to Sell

Top China Stocks To Invest In 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Teva Pharmaceutical Industries Ltd.s (NYSE: TEVA) short interest decreased to 55.84 million from the previous level of 59.40 million. Shares were trading at $17.56, in a 52-week range of $10.85 to $33.82.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Todd Campbell]

    Warren Buffett’s penchant for picking great stocks for Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) portfolio makes his quarterly stock picks must-know news for every long-term investor. Luckily, Buffett is required to file a 13F report with the Securities and Exchange Commission every quarter showing what he’s been buying, and that makes following in his footsteps easier. Last quarter, his top buys were U.S. Bancorp (NYSE:USB),Apple, Inc. (NASDAQ:AAPL), andTeva Pharmaceutical Industries (NYSE:TEVA). Should you buy these stocks for your portfolio, too?

  • [By ]

    Buffett also more than doubled his stake in generic drugmaker Teva Pharmaceuticals (NYSE: TEVA) to 40 million shares. This was a new investment in the fourth quarter and could still be a good entry point for new investors.

Top China Stocks To Invest In 2018: Aegion Corp(AEGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    LSV Asset Management decreased its position in Aegion Corp (NASDAQ:AEGN) by 5.7% in the 1st quarter, HoldingsChannel reports. The fund owned 108,700 shares of the construction company’s stock after selling 6,600 shares during the period. LSV Asset Management’s holdings in Aegion were worth $2,490,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Aegion (NASDAQ:AEGN) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aegion (AEGN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top China Stocks To Invest In 2018: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ARP Americas LP lowered its stake in shares of Allison Transmission (NYSE:ALSN) by 8.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,497 shares of the auto parts company’s stock after selling 1,400 shares during the quarter. ARP Americas LP’s holdings in Allison Transmission were worth $566,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Allison Transmission (NYSE:ALSN) announced a quarterly dividend on Thursday, May 10th, Zacks reports. Stockholders of record on Monday, May 21st will be given a dividend of 0.15 per share by the auto parts company on Thursday, May 31st. This represents a $0.60 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, May 18th.

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) – Investment analysts at Oppenheimer increased their FY2018 earnings per share (EPS) estimates for Allison Transmission in a research note issued on Monday, April 30th. Oppenheimer analyst I. Zaffino now expects that the auto parts company will post earnings of $3.79 per share for the year, up from their previous forecast of $3.32. Oppenheimer also issued estimates for Allison Transmission’s FY2019 earnings at $4.16 EPS.

Top China Stocks To Invest In 2018: USG Corporation(USG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

Best China Stocks To Watch For 2018

Source: Google Images

Review

A quick caveat – JD.com (NASDAQ:JD) is the largest e-commerce retail platform in China, as measured by net revenues. Alibaba Group Holding (NYSE:BABA) is the largest e-commerce retail platform in China, as measured by gross merchandise volume (GMV).

The JD-Alibaba relationship is akin to the Amazon.com (NASDAQ:AMZN) and eBay Inc. (NASDAQ:EBAY) history, where one company has looked to invest and grow through fulfillment facilities and transportation through the incorporation of technology, while the other has focused on technology infrastructure to develop a robust marketplace platform.

Best China Stocks To Watch For 2018: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By ]

    One of the main goals of my premium newsletter High-Yield Investing is stability. I like industries that don’t go through unpredictable hot and cold cycles. Student Transportation (NYSE: STB) is a textbook example.

  • [By Logan Wallace]

    Student Transportation Inc. (NASDAQ:STB) (TSE:STB) has been given an average rating of “Hold” by the eight brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $7.20.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Student Transportation (STB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best China Stocks To Watch For 2018: Concord Medical Services Holdings Limited(CCM)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,

Best China Stocks To Watch For 2018: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Top 10 Stocks To Watch For 2019

“The Bet” (or how your money finds its way to Wall Street)

In this section, you will encounter, early on, the story of an investment bet I made nine years ago and, next, some strong opinions I have about investing. As a starter, though, I want to briefly describe Long Bets, a unique establishment that played a role in the bet.

Long Bets was seeded by Amazon (NASDAQ:AMZN)’s Jeff Bezos and operates as a non-profit organization that administers just what you’d guess: long-term bets. To participate, “proposers” post a proposition at Longbets.org that will be proved right or wrong at a distant date. They then wait for a contrary-minded party to take the other side of the bet. When a “doubter” steps forward, each side names a charity that will be the beneficiary if its side wins; parks its wager with Long Bets; and posts a short essay defending its position on the Long Bets website. When the bet is concluded, Long Bets pays off the winning charity.

Top 10 Stocks To Watch For 2019: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Stocks To Watch For 2019: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Max Byerly]

    Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.

Top 10 Stocks To Watch For 2019: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news stories that may have effected Accern’s analysis:

    Get Pebblebrook Hotel alerts:

    Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)

    A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.

Top 10 Stocks To Watch For 2019: CommunityOne Bancorp(COB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cobinhood (CURRENCY:COB) traded up 4.7% against the U.S. dollar during the 1 day period ending at 23:00 PM Eastern on May 16th. One Cobinhood token can currently be purchased for approximately $0.0862 or 0.00001024 BTC on exchanges including Mercatox, Cobinhood and EtherDelta (ForkDelta). During the last week, Cobinhood has traded 9.9% lower against the U.S. dollar. Cobinhood has a total market capitalization of $31.24 million and $16,592.00 worth of Cobinhood was traded on exchanges in the last day.

Top 10 Stocks To Watch For 2019: ENSERVCO Corporation(ENSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Enservco (NYSEAMERICAN:ENSV) will be issuing its quarterly earnings data before the market opens on Wednesday, May 9th.

    Enservco (NYSEAMERICAN:ENSV) last issued its earnings results on Thursday, March 22nd. The oil and gas producer reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Enservco had a negative return on equity of 89.94% and a negative net margin of 43.71%. The business had revenue of $14.13 million during the quarter.

Top 10 Stocks To Watch For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Top 10 Stocks To Watch For 2019: Petroleo Brasileiro S.A.- Petrobras(PBR)

Advisors’ Opinion:

  • [By Jayson Derrick]

    Improving oil prices mean a "major change" to the investment profile of Brazil-based Petroleo Brasil/ADR (NYSE: PBR), according to Bank of America Merrill Lynch.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 34.35 million shares from the previous 31.85 million. The stock traded at $13.40 a share, in a 52-week range of $7.61 to $14.93. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 53.95 million shares from the previous 45.15 million. The stock traded at $12.65 a share, in a 52-week range of $7.61 to $13.99. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

Top 10 Stocks To Watch For 2019: ResMed Inc.(RMD)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 3: ResMed (NYSE:RMD). This is the company solving sleep apnea with its CPAP devices and this is a company that really innovated and brought that technology to the world. For people who are having trouble sleeping with clogged airways as they’re sleeping, ResMed is their best friend.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ResMed (RMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise(NASDAQ:AAXN), Grupo Aeroportuario del Pacific(NYSE:PAC), ResMed(NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation(NYSE:LYV).

Top 10 Stocks To Watch For 2019: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By ]

    CoreSite Realty (COR) : “The data centers have been hot, but the REITS have not. I’m a buyer of this stock, not a seller.”

    Hi-Crush Partners (HCLP) : “This sector has gotten way too hot.”

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Berkshire Hathaway (BRK.A)   (BRK.B) , Criticare Systems Inc.  (CMD) , Thermo Fisher Scientific (TMO) , IAC Interactive (IAC) and CoreSite Realty (COR) .

  • [By Jack Delaney]

    Take CoreSite Realty Corp. (NYSE: COR), for example. The stock price not only climbed 43.66% from 2017 to 2018, but it also pays its shareholders a dividend of $3.92 per share.

Top 10 Stocks To Watch For 2019: Gener8 Maritime, Inc.(GNRT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY NOTICE: “General Maritime Co. (GNRT) Receives $8.50 Consensus Price Target from Analysts” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3361904/general-maritime-co-gnrt-receives-8-50-consensus-price-target-from-analysts.html.

Mid-Day Market Update: Baozun Rises Following Q1 Results; Jounce Therapeutics Shares Plummet

Midway through trading Thursday, the Dow traded up 0.15 percent to 24,805.86 while the NASDAQ climbed 0.26 percent to 7,417.56. The S&P also rose, gaining 0.25 percent to 2,729.24.

Leading and Lagging Sectors

On Thursday, the energy shares rose 1.34 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 46 percent, and Sanchez Energy Corporation (NYSE: SN) up 8 percent.

In trading on Thursday, real estate shares fell 0.34 percent.

Top Headline

Walmart Inc (NYSE: WMT) reported better-than-expected results for its first quarter.

Walmart said it earned $1.14 per share in the first quarter on revenue of $120.7 billion versus Wall Street's estimate of $1.13 per share on revenue of $120.51 billion.

Walmart U.S. comp sales rose 2.1 percent, comp traffic rose 0.8 percent. Comp sales at Sam's Club rose 3.8 percent on a traffic growth of 5.6 percent. Online sales also grew 33 percent in the quarter which marks a reversal from the prior quarter's disappointing performance in the prior quarter.

Equities Trading UP

Carver Bancorp, Inc. (NASDAQ: CARV) shares shot up 88 percent to $6.88.

Shares of Loxo Oncology, Inc. (NASDAQ: LOXO) got a boost, shooting up 21 percent to $168.56. The biopharmaceutical company that focuses on medicines for patients with genetically defined cancers said its oral presentation of LOXO-292 was selected for the "Best of ASCO" program.

Baozun Inc. (NASDAQ: BZUN) shares were also up, gaining 17 percent to $52.85 after reporting Q1 results.

Equities Trading DOWN

Jounce Therapeutics, Inc. (NASDAQ: JNCE) shares dropped 32 percent to $12.02. Abstract of the Phase 1/2 ICONIC trial that evaluated JTX-2011 monotherapy as well as in combination with nivolumab showed that the company has met its target enrolment in its combination cohorts across four solid tumor types, namely gastric cancer, triple-negative breast cancer, head and neck squamous cell cancer and non-small cell lung cancer.

Shares of J C Penney Company Inc (NYSE: JCP) were down 9 percent to $2.79 after the company reported downbeat Q1 results and lowered its FY2018 guidance.

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Commodities

In commodity news, oil traded up 0.45 percent to $71.81 while gold traded down 0.22 percent to $1,288.60.

Silver traded up 0.67 percent Thursday to $16.48, while copper rose 0.65 to $3.0905.

Eurozone

European shares were higher today. The eurozone’s STOXX 600 gained 0.49 percent, the Spanish Ibex Index rose 0.83 percent, while Italy’s FTSE MIB Index rose 0.11 percent. Meanwhile the German DAX rose 0.83 percent, and the French CAC 40 climbed 0.67 percent while U.K. shares rose 0.60 percent.

Economics

Initial jobless claims increased 11,000 to 222,000 in the latest week. Economists were projecting claims to total 215,000 last week.

The Philadelphia Fed manufacturing index rose to 34.4 for May, compared to 23.3 in April. Economists expected a reading of 21.9.

The index of leading economic indicators rose 0.4 percent for April.

Domestic supplies of natural gas increased 106 billion cubic feet for the week ended May 11, the U.S. Energy Information Administration reported. Analysts expected a gain of 104 billion cubic feet.

Federal Reserve Bank of Dallas President Robert Kaplan will speak at 1:30 p.m. ET.

Data on money supply for the latest week will be released at 4:30 p.m. ET.

Top 10 Heal Care Stocks To Invest In 2018

The Florida citrus industry was already in big trouble even before Hurricane Irma started closing in. Now experts are worried that the storm could be the final straw that tips many growers into bankruptcy.

The problem until now has not been storms but a disease, known as citrus greening. It’s spread by an insect, and leaves the fruit green, bitter and unusable. As a result, Florida orange production has declined by about 50% in just the last five years.

“The citrus industry here is fighting for its very existence,” said Lisa Lochridge, spokeswoman for the Florida Fruit & Vegetable Association. “This is the last thing we need.”

Even with that reduced production, the state’s citrus industry employs more than 45,000 people and generates more than $8 billion in total sales, according to state data. If Irma does strike Florida’s orchards, it will be an economic disaster for the already struggling industry said Tom Spreen, professor emeritus at the University of Florida.

Top 10 Heal Care Stocks To Invest In 2018: STORE Capital Corporation(STOR)

Advisors’ Opinion:

  • [By Lee Jackson]

    STORE Capital Corp. Inc. (NYSE: STOR) is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market. Investors receive a 4.94% yield, and shares traded recently at $24.85. The 52-week range is $19.65 to $26.58. The consensus price target is $27.08.

  • [By Todd Campbell, Rich Smith, and Neha Chamaria]

    Dividend paying stocks historically outperform non-dividend paying stocks, but that doesn’t mean that all dividend paying companies are created equal. Some businesses are better than others, and the best businesses offer the greatest opportunity for future dividend increases. If you’re hunting for top dividend stocks that offer more than just a high yield, it could be time to consider buyingCVS Health (NYSE:CVS), Welltower (NYSE:WELL), and STORE Capital (NYSE:STOR).

  • [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

    Want proof? We asked these Motley Fool investors to highlight a dividend stock that pays a higher yield than Verizon. Here’s why they pickedTanger Factory Outlets (NYSE:SKT), Cedar Fair (NYSE:FUN), andSTORE Capital (NYSE:STOR).

Top 10 Heal Care Stocks To Invest In 2018: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Top 10 Heal Care Stocks To Invest In 2018: Oclaro, Inc.(OCLR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Oclaro Inc. (Nasdaq: OCLR) is a Silicon Valley-based semiconductor equipment company. It is a designer, manufacturer, and marketer of modules, optical components, and subsystems for data center, metro, and long-haul markets worldwide.

  • [By Leo Sun]

    Therefore Acacia could be a lucrative takeover target in its weakened state. Lumentum, for example, recently agreed to buy Oclaro (NASDAQ:OCLR) — which also relies heavily on China — for$1.7 billion.

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By ]

    Oclaro (OCLR) : “No, I don’t like anything optical. I’d go with Cisco Systems (CSCO) .”

    Stratasys (SSYS) : “If you want 3D printing, you want HP (HPQ) .”

  • [By Ezra Schwarzbaum]

    Oclaro Inc (NASDAQ: OCLR) was up 5.95 percent. Shares of the company had dropped 15.2 percent when the ban was first announced.

    Applied Optoelectronics Inc (NASDAQ: AAOI) was trading up 1.4 percent. The stock was relatively unaffected by the ban, trading down as much as 5.3 percent on April 16 but ultimately ending the day within 1 percent of its previous close.

  • [By Anders Bylund]

    Shares of Oclaro (NASDAQ:OCLR) gained 15.5% in March 2017, according to data from S&P Global Market Intelligence.

    So what

    The maker of optical networking components was off to a good start in March, but it lost all momentum when rival Finisar (NASDAQ:FNSR) reported weak earnings with mellow management comments on the state of the optical market. Finisar shares plunged 23% lower the next day, dragging Oclaro down in a 13% three-day slide.

Top 10 Heal Care Stocks To Invest In 2018: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

Top 10 Heal Care Stocks To Invest In 2018: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cott (NYSE:COT) (TSE:BCB) was upgraded by analysts at Jefferies Group from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, MarketBeat reports. The firm currently has a $17.00 price objective on the stock. Jefferies Group’s price target indicates a potential upside of 6.25% from the stock’s previous close. Jefferies Group also issued estimates for Cott’s Q2 2018 earnings at $0.06 EPS, Q3 2018 earnings at $0.14 EPS, Q4 2018 earnings at $0.01 EPS and FY2020 earnings at $0.38 EPS.

  • [By Stephan Byrd]

    Cott (NYSE:COT) (TSE:BCB) last announced its quarterly earnings results on Thursday, May 3rd. The company reported ($0.02) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.02). Cott had a net margin of 14.54% and a return on equity of 1.79%. The firm had revenue of $560.80 million for the quarter, compared to analyst estimates of $563.81 million. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. sell-side analysts anticipate that Cott will post 0.21 earnings per share for the current fiscal year.

Top 10 Heal Care Stocks To Invest In 2018: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Smart Portfolios LLC acquired a new stake in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 2,906 shares of the exchange traded fund’s stock, valued at approximately $202,000.

  • [By Stephan Byrd]

    SimpliFi Inc. lifted its position in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 0.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 156,749 shares of the exchange traded fund’s stock after purchasing an additional 967 shares during the quarter. iShares MSCI EAFE ETF accounts for about 9.0% of SimpliFi Inc.’s holdings, making the stock its 6th largest holding. SimpliFi Inc.’s holdings in iShares MSCI EAFE ETF were worth $10,922,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Invest In 2018: Tanger Factory Outlet Centers Inc.(SKT)

Advisors’ Opinion:

  • [By Jeremy Bowman, Leo Sun, and Steve Symington]

    To take advantage of that potential boom, we asked three of our retail writers for their top picks for May. See why they recommend Dollar General (NYSE:DG), Tanger Factory Outlet Centers (NYSE:SKT), and Home Depot (NYSE:HD).

  • [By Leo Sun]

    Shares of Tanger Factory Outlets (NYSE:SKT) fell 9% to an eight-year low on May 2 after the outlet owner reported itsfirst quarter earnings. Tanger beat estimates on the top and bottom lines, but also reported declines in its core business and cut its full-year guidance.

  • [By Matthew Frankel]

    Tanger Factory Outlet Centers (NYSE:SKT) has performed quite poorly lately. After a 7% drop following its first-quarter earnings release, the stock has now underperformed the S&P 500 by a staggering 69 percentage points over the past two years.

Top 10 Heal Care Stocks To Invest In 2018: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

Top 10 Heal Care Stocks To Invest In 2018: Dynagas LNG Partners LP(DLNG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Dynagas LNG Partners (NYSE:DLNG) will post its quarterly earnings results after the market closes on Wednesday, May 16th. Analysts expect Dynagas LNG Partners to post earnings of $0.17 per share for the quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Valeritas Holdings Inc (NASDAQ: VLRX) fell 25.9 percent to $1.89 in pre-market trading. Valeritas priced its 13.7 million share offering at $1.75 per share.
    Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.5 percent to $15.30 in pre-market trading after rising 9.80 percent on Monday.
    Dynagas LNG Partners LP (NYSE: DLNG) fell 5.1 percent to $9.00 in pre-market trading after slipping 1.15 percent on Monday.
    Incyte Corporation (NASDAQ: INCY) fell 5 percent to $64.80 in pre-market trading. Lilly and Incyte disclosed that the FDA Advisory Committee recommended approval of baricitinib 2mg, but not 4mg, for the treatment of moderately-to-severely active RAI.
    Casa Systems, Inc. (NASDAQ: CASA) fell 4.7 percent to $28.40 in pre-market trading after announcing a 7.35 million share common stock offering.
    Assured Guaranty Ltd. (NYSE: AGO) shares fell 4.5 percent to $34.30 in pre-market trading. The founder and president of Greenlight Capital talked about a short idea in Assured Guaranty, saying pre-tax income is likely to "collapse." He also highlighted Assured Guaranty insured $12.2 billion in below-investment grade bonds.
    The St. Joe Company (NYSE: JOE) shares fell 4 percent to $17.30 in pre-market trading.
    Masco Corporation (NYSE: MAS) shares fell 3.4 percent to $38.10 in pre-market trading

  • [By Lisa Levin]

    Dynagas LNG Partners LP (NYSE: DLNG) shares dropped 12 percent to $9.33 after the company lowered its quarterly distribution to $0.25 per common unit from $0.4225 per common unit.

  • [By Lisa Levin]

    Dynagas LNG Partners LP (NYSE: DLNG) shares dropped 12 percent to $9.33 after the company lowered its quarterly distribution to $0.25 per common unit from $0.4225 per common unit.

Top 10 Heal Care Stocks To Invest In 2018: AmerisourceBergen Corporation (Holding Co)(ABC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Recently the managers removed AmerisourceBergen Corp (NYSE: ABC) and used the proceeds from the sale to increase the position they already held in Unitedhealth Group Inc. (NYSE: UNH).

  • [By Logan Wallace]

    AmerisourceBergen (NYSE: ABC) and Trxade Group (OTCMKTS:TRXD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

  • [By Ethan Ryder]

    Alphabit (CURRENCY:ABC) traded down 14.2% against the US dollar during the 24-hour period ending at 19:00 PM Eastern on April 11th. Alphabit has a market cap of $0.00 and approximately $999.00 worth of Alphabit was traded on exchanges in the last 24 hours. One Alphabit token can now be purchased for about $33.91 or 0.00489408 BTC on cryptocurrency exchanges including C-CEX and Cryptopia. In the last week, Alphabit has traded up 2.4% against the US dollar.

Top Clean Energy Stocks To Own For 2019

Clean energy stocks in 2018are on the cusp of massive growth, as the sector is projected to expand by 500% in the United States alone…

The Energy Information Agency is projecting renewable energy production to grow 500% by 2040.

The World’s First “Universal Fuel”: Physicists have known about an unlimited source of free fuel for over 100 years. See why tech companies are investing millions in this fuel (and how to join them). Click here…

And that means right now is the time to invest in clean energy stocks before they begin to soar.

To help Money Morning readers profit from the massive industry growth ahead, we’re giving our readers one of the best clean energy stocks to buy right now. More on that pick in just a bit, but we want to first show you why the renewable energy sector is set to soar…

How Renewables Will Power Clean Energy Stocks in 2018

There are three major catalysts propelling alternative energy sources to explosive growth potential. And as the sector grows, so will renewable energy stocks…

Top Clean Energy Stocks To Own For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

Top Clean Energy Stocks To Own For 2019: Horizon Technology Finance Corporation(HRZN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Compass Horizon Funding Co. (NASDAQ:HRZN) Director Elaine A. Sarsynski acquired 3,000 shares of the business’s stock in a transaction dated Monday, May 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $30,000.00. Following the completion of the acquisition, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $50,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Top Clean Energy Stocks To Own For 2019: Southern Company (SO)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

  • [By Reuben Gregg Brewer]

    My timing, however, isn’t always so good, and I sometimes get in too early. But owning a great dividend-paying company at a fair price is better than owning a bad company at any price. Which is why I’m happy to have bought U.S. utility giant The Southern Company (NYSE:SO) and healthcare real estate investment trust (REIT) Ventas, Inc. (NYSE:VTR). And I’ll be just as happy if they fall further from here.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.7% Friday and posted a new 52-week low of $44.46 after closing Thursday at $45.25. The 52-week high is $53.51. Volume was over 6 million, about 20% above the daily average of around 4.8 million shares. The company was dropped from Neutral to Sell at Goldman Sachs on Thursday.

  • [By Ethan Ryder]

    QCI Asset Management Inc. NY trimmed its stake in Southern (NYSE:SO) by 91.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,421 shares of the utilities provider’s stock after selling 182,905 shares during the quarter. QCI Asset Management Inc. NY’s holdings in Southern were worth $733,000 as of its most recent SEC filing.

Best Clean Energy Stocks To Invest In Right Now

Call it global warming. Call it climate change. Maybe it’s a nuance, or maybe your political stance determines how you feel about this debate. 24/7 Wall St. has tracked investment in clean energy and renewable energy for years.

It turns out that 2016 broke the growth cycle for investing in clean energy — and then some.

With a new Trump administration about to take office, it looks like there is a night and day views on climate change versus the Obama administration. That makes this report something which likely cannot be ignored. After all, it was only known for less than two months that Hillary Clinton’s clean energy trends would not continue what was seen under the Obama administration. Still, it’s a big world and many other nations outside of the United States havea seriousrole in clean energy.

The news at the start of 2017 is showing a stark difference for 2016. Bloomberg New Energy Finance now shows that the total dollars of new investments into clean energy fell a whopping 18% down to $287.5 billion in 2016. While the prior year was a record of $348.5 billion, what stands out here now is that the 2016 figure is also represented as being 9% lower than the $315 billion invested into clean energy in 2014.

Best Clean Energy Stocks To Invest In Right Now: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

Best Clean Energy Stocks To Invest In Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

Best Clean Energy Stocks To Invest In Right Now: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    BAE Systems (BAESY) and other defense stocks gained on Friday morning after President Donald Trump’s strike on Syria prompted investors to consider the possibility of greater Western involvement in the Syrian conflict.

  • [By SEEKINGALPHA.COM]

    Rheinmetall is currently trading at 15.7x forward earnings and 2.5x book value, a valuation that is closer to its automotive suppliers peers. Compared to its defense peers, its valuation is clearly cheap, as shown in the next table. This shows that Rheinmetall is usually benchmarked against its auto peers, even though 53% of its sales and 41% of operating income have come from its defense unit in the past year.

    P/E P/BV Rheinmetall 15.7 2.5 Continental AG 12.4 2.9 Valeo 13.1 3.6 Brembo (OTC:BRBOF) 17.0 5.2 Leoni (OTC:LNNNY) 13.2 1.9 Auto Peers Average 14.3 3.2 Airbus 24.0 6.8 Leonardo 16.8 2.0 BAE Systems (OTCPK:BAESY) 18.5 5.7 Thales (OTCPK:THLEY) 22.4 4.3 Defense Sector Average 19.2 4.4

    Source: Bloomberg

Best Clean Energy Stocks To Invest In Right Now: Hanwha Q CELLS Co., Ltd. (HQCL)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

Best Clean Energy Stocks To Invest In Right Now: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Wendys Co (NASDAQ: WEN) to report its quarterly earnings at $0.06 per share on revenue of $352.08 million. Wendys shares rose 1.79 percent to $11.38 in after-hours trading.

  • [By Monica Gerson]

    Wendys Co (NASDAQ: WEN) is expected to report its quarterly earnings at $0.06 per share on revenue of $352.08 million.

    Canadian Solar Inc. (NASDAQ: CSIQ) is estimated to report its quarterly earnings at $0.14 per share on revenue of $663.74 million.

  • [By Michael Flannelly]

    Argus Research upgraded fast food restaurant operator The Wendy’s Co (WEN) on Thursday, noting that the company’s store remodeling and new menus should help drive higher sales.

    The analysts upgraded WEN from “Hold” to “Buy” and see shares reaching $10. This price target suggests a 21% upside to the stock’s Wednesday closing price of $8.25.

    Wendy’s shares were up 24 cents, or 2.91%, during early morning trading on Thursday. The stock is up 54.19% year-to-date.

Best Clean Energy Stocks To Invest In Right Now: Navigant Consulting, Inc.(NCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Navigant Consulting, Inc. (NYSE: NCI) were down 14 percent to $17.02 after the company posted downbeat quarterly results.

    Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.